{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:28:26Z","timestamp":1780442906788,"version":"3.54.1"},"reference-count":49,"publisher":"CSIRO Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":103,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Philippines has witnessed a 550% increase in HIV cases between 2010 and 2023, disproportionately affecting men who have sex with men (MSM). Despite the national rollout of pre-exposure prophylaxis (PrEP) in 2021, uptake remains limited, with structural and individual barriers, such as PrEP-associated cost and stigma influencing engagement. This study explores Filipino MSM\u2019s preferences for PrEP service attributes to inform person-centered HIV prevention strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional online survey, as part of the PrEP APPEAL multicountry study, was conducted among MSM in the Philippines in May to November 2022. A discrete choice experiment embedded in the survey assessed preferences for six PrEP service attributes, including type, access location, cost, side-effects, visit frequency and additional services. Preferences were analyzed using random parameters logit and latent class models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 2282 MSM respondents (mean age\u00a0=\u00a028.8\u00a0years, s.d.\u00a0=\u00a07.9), 68.9% had heard of PrEP, yet only 18.3% were current users. In the pooled analysis, cost, PrEP type, and side-effects were the most influential attributes. MSM preferred free oral PrEP but willing to pay up to Philippine Peso (PHP) 1000 (AUD 25) per month (\u03b2\u00a0=\u00a00.06, P\u00a0=\u00a00.032), services accessed through community-led clinics (\u03b2\u00a0=\u00a00.12, P\u00a0=\u00a00.001), and yearly clinic visits (\u03b2\u00a0=\u00a00.14, P\u00a0&amp;lt;\u00a00.001). The discrete choice experiment revealed four subgroups with diverse preferences: (1) the \u2018Long-Acting Preventive Realists\u2019 (27.3%), (2) the \u2018Cost-Conscious Annually Visiting Pragmatist\u2019 (22.1%), (3) the \u2018Community-based organizations-Trusting Lowkey Clinic Visitors\u2019 (33.0%), and the \u2018Easy-Going PrEP-Hesitants\u2019. Class 1 participants showed preferences across type of PrEP (29.2%), cost (26.5%) and side-effects (22.1%). In contrast, cost was the dominant factor for Classes 2 (54.9%), 3 (49.2%) and 4 (45.7%). Although, these latter classes also considered type of PrEP (11.6%, 15.2% and 16.5%, respectively) and side-effects (13.3%, 11.3% and 15.9%, respectively), but were less influential compared with Class 1. Across all classes, location and inclusion of extra services had relatively low importance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite growing awareness, uptake among Filipino MSM remains limited. Findings highlight diverse user preferences, reinforcing the need for differentiated, person-centered PrEP models. Expanding community-based access, ensuring affordability and integrating user-informed features can optimize uptake, whereas sustainable financing and phased rollout of newer modalities are essential for national scale-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh25070","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T01:30:15Z","timestamp":1754530215000},"source":"Crossref","is-referenced-by-count":2,"title":["The awareness and preferences in PrEP access, type of service delivery, and willingness to pay among men who have sex with men in the Philippines: a discrete choice experiment"],"prefix":"10.1071","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0249-8706","authenticated-orcid":true,"given":"Rodenie Arnaiz","family":"Olete","sequence":"first","affiliation":[{"name":"ASustained Health Initiatives of the Philippines (SHIP) Inc, Mandaluyong City, the Philippines. Email: kleyritana@ship.ph; patrickceustaquio@gmail.com"},{"name":"BDepartment of Public Health, National Cheng Kung University (NCKU), Tainan City, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8522-1122","authenticated-orcid":true,"given":"Patrick","family":"Eustaquio","sequence":"additional","affiliation":[{"name":"ASustained Health Initiatives of the Philippines (SHIP) Inc, Mandaluyong City, the Philippines. Email: kleyritana@ship.ph; patrickceustaquio@gmail.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9712-9262","authenticated-orcid":true,"given":"Warittha","family":"Tieosapjaroen","sequence":"additional","affiliation":[{"name":"CSchool of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic, Australia. Email: WTieosapjaroen@mshc.org.au; doctorjasonong@gmail.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Leyritana","sequence":"additional","affiliation":[{"name":"ASustained Health Initiatives of the Philippines (SHIP) Inc, Mandaluyong City, the Philippines. Email: kleyritana@ship.ph; patrickceustaquio@gmail.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cassell","sequence":"additional","affiliation":[{"name":"DFHI 360, Atlanta, GA, USA. Email: MCassell@fhi360.org"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-7403","authenticated-orcid":true,"given":"Jason J.","family":"Ong","sequence":"additional","affiliation":[{"name":"CSchool of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic, Australia. Email: WTieosapjaroen@mshc.org.au; doctorjasonong@gmail.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2629-6407","authenticated-orcid":true,"given":"Heather-Marie A.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"EJoint United Nations Programme on HIV\/AIDS (UNAIDS), Geneva, Switzerland. Email: SchmidtH@unaids.org"},{"name":"FWorld Health Organization (WHO), Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0036-3165","authenticated-orcid":true,"given":"Nittaya","family":"Phanuphak","sequence":"additional","affiliation":[{"name":"GInstitute of HIV Research and Innovation (IHRI), Bangkok, Thailand. Email: nittaya.p@ihri.org"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9581-1011","authenticated-orcid":true,"given":"Curtis","family":"Chan","sequence":"additional","affiliation":[{"name":"HKirby Institute, UNSW Sydney, Sydney, NSW, Australia. Email: cchan@kirby.unsw.edu.au; bbavinton@kirby.unsw.edu.au"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-8278","authenticated-orcid":true,"given":"Benjamin R.","family":"Bavinton","sequence":"additional","affiliation":[{"name":"HKirby Institute, UNSW Sydney, Sydney, NSW, Australia. Email: cchan@kirby.unsw.edu.au; bbavinton@kirby.unsw.edu.au"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"2025111812245982300_R1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS data 2024. 2024. Available at https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/2024_unaids_data [cited 22 April 2025]"},{"key":"2025111812245982300_R2","unstructured":"Department of Health - Philippines. 2024 HIV & AIDS Surveillance of the Philippines (Q4 Report). 2024. Available at https:\/\/bit.ly\/HASP2024Q4 [cited 19 April 2025]"},{"key":"2025111812245982300_R3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1071\/SH20134","article-title":"The continuing HIV epidemic among men who have sex with men and transgender women in the ASEAN region: implications for HIV policy and service programming.","volume":"18","author":"van Griensven","year":"2021","journal-title":"Sex Health"},{"key":"2025111812245982300_R4","unstructured":"AVAC. Data by Country - PrEPWatch. the Philippines: PrEPWatch Country Overview. Available at https:\/\/www.prepwatch.org\/countries\/philippines\/ [cited 3 March 2025]"},{"key":"2025111812245982300_R5","unstructured":"Department of Health - Epidemiology Bureau. 2022 integrated HIV behavioral and serologic surveillance (IHBSS). 2024. Available at https:\/\/bit.ly\/2022IHBSS [cited 28 December 2024]"},{"issue":"5","key":"2025111812245982300_R6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048478","article-title":"Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations.","volume":"12","author":"O Murchu","year":"2022","journal-title":"BMJ Open"},{"key":"2025111812245982300_R7","doi-asserted-by":"publisher","first-page":"e788","DOI":"10.1016\/S2352-3018(19)30238-3","article-title":"Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline.","volume":"6","author":"Coelho","year":"2019","journal-title":"Lancet HIV"},{"issue":"1","key":"2025111812245982300_R8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107009","article-title":"Lenacapavir: a novel injectable HIV-1 capsid inhibitor.","volume":"63","author":"Hitchcock","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"2025111812245982300_R9","unstructured":"Department of Health. Philippines-Interim-National-PrEP-Guidelines-2021. 2021. Available at https:\/\/www.prepwatch.org\/resources\/philippines-interim-national-prep-guidelines-2021\/ [cited 15 December 2024]"},{"key":"2025111812245982300_R10","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed8050258","article-title":"The state of the HIV epidemic in the Philippines: progress and challenges in 2023.","volume":"8","author":"Gangcuangco","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"2025111812245982300_R11","unstructured":"Department of Health - Epidemiology Bureau. 2024 HIV & AIDS Surveillance of the Philippines (Q3 Report). 2024. Available at https:\/\/bit.ly\/HASP2024Q3 [cited 28 December 2024]"},{"key":"2025111812245982300_R12"},{"issue":"3","key":"2025111812245982300_R13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282644","article-title":"Implementation of unassisted and community-based HIV Self-Testing (HIVST) during the COVID-19 pandemic among Men-who-have-sex-with-Men (MSM) and Transgender Women (TGW): a demonstration study in Metro Manila, the Philippines.","volume":"18","author":"Rosadi\u00f1o","year":"2023","journal-title":"PLoS ONE"},{"issue":"1","key":"2025111812245982300_R14","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-12705-z","article-title":"Outcomes of a community-led online-based HIV self-testing demonstration among cisgender men who have sex with men and transgender women in the Philippines during the COVID-19 pandemic: a retrospective cohort study.","volume":"22","author":"Eustaquio","year":"2022","journal-title":"BMC Public Health"},{"key":"2025111812245982300_R15","doi-asserted-by":"publisher","DOI":"10.1590\/0034-7167-2021-0963","article-title":"Barriers to pre-exposure prophylaxis (Prep) use for HIV: an integrative review.","volume":"76","author":"Antonini","year":"2023","journal-title":"Rev Bras Enferm"},{"issue":"1","key":"2025111812245982300_R16","doi-asserted-by":"publisher","DOI":"10.1186\/s43058-022-00254-w","article-title":"A pragmatic approach to identifying implementation barriers and facilitators for a novel pre-exposure prophylaxis (PrEP) delivery model at public facilities in urban Uganda.","volume":"3","author":"Thomas","year":"2022","journal-title":"Implement Sci Commun"},{"key":"2025111812245982300_R17","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.20.1.21580","article-title":"Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis.","volume":"20","author":"Yi","year":"2017","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"2025111812245982300_R18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1377\/hlthaff.2023.00808","article-title":"Estimating the impact of out-of-pocket cost changes on abandonment of HIV pre-exposure prophylaxis.","volume":"43","author":"Dean","year":"2024","journal-title":"Health Aff"},{"key":"2025111812245982300_R19","unstructured":"World Health Organization (WHO). Update to WHO implementation guidance TECHNICAL BRIEF Differentiated and simplified pre-exposure prophylaxis for HIV prevention. 2022. Available at https:\/\/www.who.int\/publications\/i\/item\/9789240053694 [cited 15 December 2024]"},{"key":"2025111812245982300_R20","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.18.2.19434","article-title":"Tailored combination prevention packages and PrEP for young key populations.","volume":"18","author":"Pettifor","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"2025111812245982300_R21","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26323","article-title":"ChemsexPH: the association between chemsex, HIV status and adherence to antiretroviral therapy among men who have sex with men in the Philippines.","volume":"27","author":"Olete","year":"2024","journal-title":"J Int AIDS Soc"},{"issue":"15","key":"2025111812245982300_R22","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1097\/qad.0000000000004005","article-title":"Changes in HIV preexposure prophylaxis awareness and use among men who inject drugs who have sex with men by sexual identity in 19 US urban areas.","volume":"38","author":"Eustaquio","year":"2024","journal-title":"AIDS"},{"key":"2025111812245982300_R23","unstructured":"Chan C, Fraser D, Schmidt HM, Green KE, Cassell MM, Ong JJ, et al. PrEP product awareness, preferences, and past experiences among transgender women and men who have sex with Men in Asia and Australia: the PrEP APPEAL study report. Kirby Institute; 2023."},{"key":"2025111812245982300_R24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","article-title":"Discrete choice experiments in health economics: past, present and future.","volume":"37","author":"Soekhai","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"2025111812245982300_R25","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jval.2022","article-title":"The sensitivity and specificity of repeated and dominant choice tasks in discrete choice experiments.","volume":"25","author":"Jonker","year":"2022","journal-title":"Value Health"},{"issue":"1","key":"2025111812245982300_R26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41264-5","article-title":"Pre-exposure prophylaxis service among men who have sex with men in Malaysia: findings from a discrete choice experiment.","volume":"13","author":"Dubov","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"2025111812245982300_R27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","article-title":"Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force.","volume":"19","author":"Hauber","year":"2016","journal-title":"Value Health"},{"key":"2025111812245982300_R28","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2024. Available at https:\/\/www.r-project.org\/ [cited 7 June 2025]"},{"key":"2025111812245982300_R29","unstructured":"Econometric Software Inc. NLOGIT. Plainview, New York, USA; 2016. Available at https:\/\/www.limdep.com\/ [cited 7 June 2025]"},{"issue":"1","key":"2025111812245982300_R30","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-023-00528-w","article-title":"Pre-exposure prophylaxis uptake for high-risk men who have sex with men in China: a multi-city cross-sectional survey.","volume":"20","author":"Zhang","year":"2023","journal-title":"AIDS Res Ther"},{"issue":"1","key":"2025111812245982300_R31","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10614-1","article-title":"Awareness, willingness, and uptake of pre-exposure prophylaxis (PrEP) among men who have sex with men in Ghana.","volume":"25","author":"Apreku","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2025111812245982300_R32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jve.2024.100382","article-title":"Identifying patterns of sexual behaviors and PrEP uptake characteristics among MSM who were eligible for PrEP: a national cross-section study.","volume":"10","author":"Liu","year":"2024","journal-title":"J Virus Erad"},{"key":"2025111812245982300_R33","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26438","article-title":"PrEP use and willingness cascades among GBMSM in 15 Asian countries\/territories: an analysis of the PrEP APPEAL survey.","volume":"28","author":"Wirawan","year":"2025","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"2025111812245982300_R34","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-12398-1","article-title":"PrEP demand creation strategies for adolescents at increased risk of HIV infection in S\u00e3o Paulo, Brazil: a cost-consequence analysis.","volume":"25","author":"Cerchiari","year":"2025","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"2025111812245982300_R35","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1071\/SH18065","article-title":"Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand.","volume":"15","author":"Phanuphak","year":"2018","journal-title":"Sex Health"},{"key":"2025111812245982300_R36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100217","article-title":"High PrEP uptake, adherence, persistence and effectiveness outcomes among young Thai men and transgender women who sell sex in Bangkok and Pattaya, Thailand: findings from the open-label combination HIV prevention effectiveness (COPE) study.","volume":"15","author":"Weir","year":"2023","journal-title":"Lancet Reg Health"},{"key":"2025111812245982300_R37","doi-asserted-by":"publisher","DOI":"10.1177\/21501319221147254","article-title":"Primary care provider HIV PrEP knowledge, attitudes, and prescribing habits: a cross-sectional survey of late adopters in rural and suburban practice.","volume":"14","author":"Sell","year":"2023","journal-title":"J Prim Care Community Health"},{"key":"2025111812245982300_R38","unstructured":"Department of Health (Philippines). Department Circular No. 2024-0507: HIV Pre-Exposure Prophylaxis (PrEP) Programmatic Targets (2024\u20132026). Manila; 2024. Available at https:\/\/doh.gov.ph\/dpcb\/omnibus-health-guidelines"},{"issue":"3","key":"2025111812245982300_R39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0004005","article-title":"Prevent with pleasure: a systematic review of HIV public communication campaigns incorporating a pleasure-based approach.","volume":"5","author":"Muschialli","year":"2025","journal-title":"PLOS Glob Public Health"},{"key":"2025111812245982300_R40","unstructured":"World Health Organization. Long-acting injectable cabotegravir for HIV prevention. Geneva; 2022. Available at https:\/\/www.who.int\/publications\/i\/item\/9789240054097 [cited 23 April 2025]"},{"key":"2025111812245982300_R41","article-title":"Guidelines on lenacapavir for HIV prevention and testing strategies for long\u2011acting injectable pre\u2011exposure prophylaxis.","author":"World Health Organization","year":"2025"},{"key":"2025111812245982300_R42","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26362","article-title":"An observational cohort study evaluating PrEP reach, engagement and persistence through a community-based mobile clinic in Miami-Dade County, Florida.","volume":"27","author":"Doblecki-Lewis","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"2025111812245982300_R43","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11904-021-00578-7","article-title":"Novel platforms for biomedical HIV prevention delivery to key populations \u2014 community mobile clinics, peer-supported, pharmacy-led PrEP delivery, and the use of telemedicine.","volume":"18","author":"Rousseau","year":"2021","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025111812245982300_R44","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s11904-022-00630-0","article-title":"Telehealth interventions for HIV in low- and middle-income countries.","volume":"19","author":"Phan","year":"2022","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025111812245982300_R45","unstructured":"Philippine Health Insurance Corporation. Philhealth reinforces support for Filipinos living with HIV\/AIDS. Philippine Health Insurance Corporation; 2025."},{"key":"2025111812245982300_R46","doi-asserted-by":"publisher","DOI":"10.2196\/67445","article-title":"Agreements and disagreements between professionals and users about the experience of a telehealth service for HIV pre-exposure prophylaxis (TelePrEP): qualitative interview study.","volume":"27","author":"Santos","year":"2025","journal-title":"J Med Internet Res"},{"issue":"10","key":"2025111812245982300_R47","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40273-014-0181-7","article-title":"Reconceptualising the external validity of discrete choice experiments.","volume":"32","author":"Lancsar","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"2025111812245982300_R48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.trb.2009.12.012","article-title":"Hypothetical bias, choice experiments and willingness to pay.","volume":"44","author":"Hensher","year":"2010","journal-title":"Transp Res Part B Methodol"},{"issue":"8","key":"2025111812245982300_R49","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10198-018-0954-6","article-title":"How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity.","volume":"19","author":"Quaife","year":"2018","journal-title":"Eur J Health Econ"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH25070\/1359676\/sh25070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH25070\/1359676\/sh25070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T17:25:06Z","timestamp":1763486706000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/22\/4\/SH25070\/199823\/The-awareness-and-preferences-in-PrEP-access-type"}},"subtitle":[],"editor":[{"given":"Donaldson","family":"Conserve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8,29]]}},"URL":"https:\/\/doi.org\/10.1071\/sh25070","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"article-number":"SH25070"}}